Latest filing published 30 Apr 2026 for Zylox-Tonbridge Medical Technology Co., Ltd., €97k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Wang Hongbo: trading record in brief
All filings by Wang Hongbo on record concern Zylox-Tonbridge Medical Technology Co., Ltd., in the capacity of chief executive. Over a trading history stretching from 17 April 2026 to 29 April 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 30 April 2026, reports a transaction of €97k in Zylox-Tonbridge Medical Technology Co., Ltd. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Wang Hongbo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,250 shares0.013% mcap31.7% of flowShareXHKGHKEX:DA20260430E00243
- 9,000 shares0.029% mcap68.3% of flowShareXHKGHKEX:DA20260420E00387
2 of 2 declarations